Financhill
Back

Check Point Software Technologies Vs. MoonLake Immunotherapeutics Industry Stock Comparison

Sell
49

CHKP
Check Point Software Technologies

Last Price:
$223.41
Seasonality Move:
3.47%
Buy
57

MLTX
MoonLake Immunotherapeutics

Last Price:
$56.63
Seasonality Move:
12.1%
Sell
49
Check Point Software Technologies (CHKP) is a Sell

Is Check Point Software Technologies a Buy, Sell or Hold?

  • The current Check Point Software Technologies [CHKP] share price is $222.89. The Score for CHKP is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • CHKP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
MoonLake Immunotherapeutics (MLTX) is a Buy

Is MoonLake Immunotherapeutics a Buy, Sell or Hold?

  • The current MoonLake Immunotherapeutics [MLTX] share price is $53.57. The Score for MLTX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • MLTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CHKP Stock Price Chart

What is Check Point Software Technologies's stock price today?

  • The Check Point Software Technologies share price today is $222.89
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CHKP is experiencing slight selling pressure.

MLTX Stock Price Chart

What is MoonLake Immunotherapeutics's stock price today?

  • The MoonLake Immunotherapeutics share price today is $53.57
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MLTX is experiencing slight buying pressure.

CHKP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 59.28 Buy
Relative Strength Index (14 RSI): 52.37 Buy
Chaikin Money Flow: -85691 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (217.1 - 223.9) Buy
Bollinger Bands (100): (215.21 - 227.51) Buy

MLTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 14.36 Buy
Relative Strength Index (14 RSI): 68.35 Buy
Chaikin Money Flow: 48187 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.88 - 51.46) Buy
Bollinger Bands (100): (37.05 - 46.75) Buy

CHKP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 218.94 Buy
20-day SMA: 220.61 Buy
50-day SMA: 222.24 Buy
200-day SMA: 207.32 Buy
8-day EMA: 206.4 Buy
20-day EMA: 147.14 Buy
50-day EMA: 78.57 Buy
200-day EMA: 23.01 Buy

MLTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 52.06 Buy
20-day SMA: 49.32 Buy
50-day SMA: 44.91 Buy
200-day SMA: 45.51 Buy
8-day EMA: 49.17 Buy
20-day EMA: 34.47 Buy
50-day EMA: 18.24 Buy
200-day EMA: 5.31 Buy

Check Point Software Technologies Earnings Growth & CHKP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.19 per share, an increase next quarter of $0.14 per share, an increase this year of $0.80 per share, and an increase next year of $0.90 per share.

MoonLake Immunotherapeutics Earnings Growth & MLTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.11 per share, a decrease this year of $1.20 per share, and a decrease next year of $0.62 per share.

Check Point Software Technologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

MoonLake Immunotherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):